logo image
search icon
Deep Venous Disease Treatment Devices Market

Deep Venous Disease Treatment Devices Market Size, Share & Trends Analysis Report By Products (Thrombectomy and Thrombolysis Devices, Inferior Vena Cava (IVC) Filters, Peripheral Vascular Stents, PTA Balloon Catheters, Accessory Devices, and Compression Devices/Stockings) and End-user And Segment Forecasts, 2023-2031

Report ID : 1815 | Published : 2023-05-23 | Pages: 180 | Format: PDF/EXCEL

The Global Deep Venous Disease Treatment Devices Market Size is valued at 1.24 billion in 2022 and is predicted to reach 2.20 billion by the year 2031 at a 6.8% CAGR during the forecast period for 2023-2031.

Vein-related illnesses are conditions that damage the body's veins. One of the most prevalent disorders brought on by harmed vessel walls and valves is varicose veins. According to an article in the Journal of the American Heart Association, around 23% of adults in the United States have varicose veins. Venous reflux disease is treated using a variety of techniques, including ablation, sclerotherapy injection, ligation or stripping, and supportive care.

Deep Venous Disease Treatment Devices Market

The market is driven by elements such as the rise in deep vein disease incidence, which increases the demand for treatment devices. The rise in deep venous disease diagnoses in hospitals, which increases the need for preventative devices, and the rise in deep venous disease awareness drives the development of deep venous disease devices in the market.

However, producers and consumers have suffered due to the pandemic. The number of treatments substantially decreased since varicose vein surgeries are not urgent. A decrease also influenced the revenue streams of the manufacturers in varicose vein surgeries or procedures due to limitations on travel. Manufacturers are taking several strategic actions to recover from COVID-19. To enhance the technology and test findings associated with the pet food flavors and ingredients market, the players are engaging in several R&D activities, product launches, and strategic collaborations. 

Competitive Landscape:

Some of the Deep Venous Disease Treatment Devices market players are:

  • Abbott Laboratories
  • AndraTec GmbH
  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Cardinal Health
  • Cook Group
  • Innova Vascular, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Nipro Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Surmodics, Inc. (Vetex Medical Ltd.)
  • Teleflex Incorporated
  • Terumo Corporation

Market Segmentation:

The Deep Venous, Disease Treatment Devices market, is segmented based on products and End-user. Product segment includes Thrombectomy and Thrombolysis Devices, Inferior Vena Cava (IVC) Filters, Peripheral Vascular Stents, PTA Balloon Catheters, Accessory Devices, and Compression Devices/Stockings. By End-User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers, and Homecare.

Based On Product, The Accessory Segment Is Accounted As A Major Contributor In The Deep Venous Disease Treatment Devices Market

During the projected period, the growing elderly population and the rising prevalence of cardiovascular disorders are anticipated to be the key drivers of the accessory device segment's growth. Cardiovascular illnesses are more prone to strike the elderly population. Over 20.8% of the European population was 65 years or older, according to Ageing Europe Statistics, 2021. Between 2021 and 2100, it is predicted that the proportion of Europeans 80 years of age or older will rise from 6.0% to 14.6%, a two-and-a-half-fold increase. Additionally, the growing desire for minimally invasive procedures will probably fuel market expansion. For instance, a minimally invasive procedure called cardiac catheterization uses thin, elastic tubes called catheters to direct them via blood vessels to the problematic areas to identify and treat several heart and vascular disorders, including May-Thurner syndrome.

Hospital And Clinic Segment Witness Growth At A Rapid Rate

Due to a growth in hospitals and surgery centers, which was the largest contributor depending on end-user in 2022, is anticipated to keep up its dominance during the projected period. However, because ambulatory surgery centers are more affordable than traditional hospitals, this market segment is predicted to develop significantly during the forecast period.

In The Region, The North America Deep Venous Disease Treatment Devices Market Holds A Significant Revenue Share

North America held a share of revenue of approximately 45.0%, dominating the market in 2022. This is mostly caused by a sizable patient population that values appearance. Due to the obvious results and safety, many are eager to undergo cosmetic operations. The proof of the safety and effectiveness of laser therapy has contributed to lowering the stigma associated with cosmetic procedures and fostering societal acceptance of laser treatments, particularly among males. The region with the quickest growth is anticipated to be Asia Pacific. Due to its huge aging population, growing disposable money, and growing knowledge of these procedures, the Asia Pacific region is anticipated to have significant growth in the years to come. Because of the various legislative considerations that affect product availability between nations, the market is extremely diversified.

Deep Venous Disease Treatment Devices Market Report Scope:

Report Attribute

Specifications

Market size value in 2022

USD 1.24 Bn

Revenue forecast in 2031

USD 2.20 Bn

Growth rate CAGR

CAGR of 6.8 % from 2023 to 2031

Quantitative units

Representation of revenue in US$ Billion and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

Products, End-user

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

Abbott Laboratories, AndraTec GmbH, AngioDynamics, Inc., Boston Scientific Corporation, Cardinal Health, Cook Group, Innova Vascular, Inc., Koninklijke Philips N.V., Medtronic plc, Nipro Corporation, Penumbra, Inc., Stryker Corporation, Surmodics, Inc. (Vetex Medical Ltd.), Teleflex Incorporated, and Terumo Corporation.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Deep Venous Disease Treatment Devices Market Snapshot

Chapter 4. Global Deep Venous Disease Treatment Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:

5.2.1. Thrombectomy and Thrombolysis Device
5.2.2. Inferior Vena Cava (IVC) Filter
5.2.3. Peripheral Vascular Stent
5.2.4. PTA Balloon Catheter
5.2.5. Accessory Device
5.2.6. Compression Device/Stockings

Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis

6.1. by End-users & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-users:

6.2.1. Hospitals and Clinics
6.2.2. Ambulatory Surgical Centres
6.2.3. Home-Care

Chapter 7. Deep Venous Disease Treatment Devices Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.1.2. North America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.1.3. North America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.2. Europe

7.2.1. Europe Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.2.2. Europe Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.2.3. Europe Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.3. Asia Pacific

7.3.1. Asia Pacific Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.3.2. Asia Pacific Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.3.3. Asia Pacific Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.4. Latin America

7.4.1. Latin America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.4.2. Latin America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.4.3. Latin America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.5.2. Middle East & Africa Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.5.3. Middle East & Africa Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles


8.2.1. Abbott Laboratories
8.2.2. AndraTec GmbH
8.2.3. AngioDynamics, Inc.
8.2.4. Boston Scientific Corporation
8.2.5. Cardinal Health
8.2.6. Cook Group
8.2.7. Innova Vascular, Inc.
8.2.8. Koninklijke Philips N.V.
8.2.9. Medtronic plc
8.2.10. Nipro Corporation
8.2.11. Penumbra, Inc.
8.2.12. Stryker Corporation
8.2.13. Surmodics, Inc. (Vetex Medical Ltd.)
8.2.14. Teleflex Incorporated
8.2.15. Terumo CorporationCardinal Health Inc.
8.2.16. Cordis Corp
8.2.17. Endologix Inc
8.2.18. Terumo Medical Corporation
8.2.19. Other Prominent Players

Segmentation of Deep Venous Disease Treatment Devices Market-

Deep Venous Disease Treatment Devices Market By Product-

  • Thrombectomy and Thrombolysis Device
  • Inferior Vena Cava (IVC) Filter
  • Peripheral Vascular Stent
  • PTA Balloon Catheter
  • Accessory Device
  • Compression Device/Stockings

Deep Venous Disease Treatment Devices Market

Deep Venous Disease Treatment Devices Market By End User-

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Homecare

Deep Venous Disease Treatment Devices Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Deep Venous Disease Treatment Devices Market?

Deep Venous Disease Treatment Devices Market expected to grow at a 6.8% CAGR during the forecast period for 2023-2031

Abbott Laboratories, AndraTec GmbH, AngioDynamics, Inc., Boston Scientific Corporation, Cardinal Health, Cook Group, Innova Vascular, Inc., Koninklijk

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach